Manufacturing
Manufacturableby design
A medicine has to be made reliably at scale. We build manufacturability into design from the first cycle, and partner with qualified GMP manufacturers for production.
- Synthesis-aware designRoutes that are short, safe and scalable — scored before a molecule is chosen.
- Developable biologicsExpression, stability and aggregation predicted before cell-line work.
- Qualified CDMO partnersGMP manufacturing through audited contract development organisations.
- Resilient supplyDual-source strategies for critical materials.
Why it matters
Late surprises are the most expensive ones
A molecule that is potent but impossible to make at scale, or an antibody that aggregates at clinical concentrations, can stall a programme for a year. Predicting these problems during design costs almost nothing.
ARYAN AI does not operate its own GMP facility. When programmes need clinical material, we work with contract development and manufacturing organisations that meet current Good Manufacturing Practice.
- Route scoring during design
- Developability gates for biologics
- Quality agreements with every CDMO